Synovial Sarcoma - Online Support Group

Clinical Trials


Personal Experience with Clinical Trials Clinical Trials and Research Updates
Topic Replies Activity
About the Clinical Trials category 1 January 6, 2017
Propranolol 3 April 4, 2018
T cells modified with CRISPR 1 January 17, 2018
ACTolog IMA101 8 January 13, 2018
Pembrolizumab (Keytruda) and Radiotherapy 2 November 22, 2017
Tinostamustine (EDO-S101) 2 November 22, 2017
Pembrolizumab 14 July 22, 2016
The Liddy Shriver Early Career Research Award 1 November 11, 2017
Circulating Tumor Cells in Synovial Sarcoma 5 November 9, 2017
ATR Inhibitors 1 October 18, 2017
CMB305 + Atezolizumab Phase 2 trial 12 October 18, 2017
M8891. Clinical Trial 2 September 21, 2017
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR 4 September 16, 2017
Sunitinib (Sutent) Plus Nivolumab (Opdivo) 1 September 15, 2017
Olaratumab with AIM 1 September 15, 2017
Nivolumab and Ipilimumab Phase 2 Trial 1 August 5, 2017
$500,000 Grant for Study on Synovial Sarcoma 1 August 1, 2017
PEN-866 Phase 1/2 Trial 1 July 19, 2017
SBRT and PD-1 or PD-L1 inhibitor 1 July 19, 2017
Nivolumab with or without Votrient (Pazopanib) 2 July 19, 2017
New research on Synovial Sarcoma of the head and neck! Published June 2017 3 July 16, 2017
ImmTAC from Immunocore 1 July 7, 2017
Has anybody tried TH-302? 7 June 27, 2017
Adjuvant Chemotherapy 1 June 10, 2017
NC-6300 (Nanoparticle Epirubicin) 1 June 1, 2017
Combination of Aldoxorubicin and Ifosfamide 1 May 21, 2017
https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2015-1071.html 2 May 21, 2017
Talazoparib Plus Irinotecan 1 May 19, 2017
Anyone try Monoclonal Antibody Targeting Frizzled Homolog 10 (SYNFRIZZ)? 3 May 19, 2017
Factors Associated with Ifosfamide Neurotoxicity 1 May 19, 2017